Veronica G.H. Jordan serves as the Board and Compensation Committee Chair. Since 2007, she has served as an advisor to companies developing novel healthcare products and services. Previously, from 2001 to 2006, she was President and Chief Executive Officer of Medelle Corporation, a medical device company in women’s health. Prior to that, Dr. Jordan served for fourteen years in various executive positions at PAREXEL International Corporation. Earlier, she held business leadership roles at Biogen and managed an R&D department for Baxter International. Dr. Jordan served as a director of Albany Molecular Research Inc. (formerly Nasdaq:AMRI) from 2006 to 2016. She currently serves on the board of Bicycle Therapeutics (Nasdaq: BCYC) and was previously Board Chair for Royal Neighbors of America, a private life insurance company.
In addition, Dr. Jordan currently serves on the board of The Ovarian Cancer
Research Alliance, a not-for-profit organization focused on research, advocacy
and patient support. She earned a B.Sc. in Biochemistry from Cambridge
University and a Ph.D. in Biochemistry/Cell Biology from Oxford University. Dr.
Jordan holds an Executive Masters Professional Director Certification from the
American College of Corporate Directors.